Small EJ - Search Results

1

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma.

Rini BI, Weinberg V, Shaw V, Scott J, Bok R, Park JW, Small EJ. Rini BI, et al. Among authors: small ej. Cancer. 2004 Jul 1;101(1):90-5. doi: 10.1002/cncr.20313. Cancer. 2004. PMID: 15221993 Free article. Clinical Trial.

2

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.

Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ. Small EJ, et al. Cancer. 1994 Jun 1;73(11):2803-7. doi: 10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6. Cancer. 1994. PMID: 8194022 Clinical Trial.

3

Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens.

Wolf JS Jr, Aronson FR, Small EJ, Carroll PR. Wolf JS Jr, et al. Among authors: small ej. J Surg Oncol. 1994 Jan;55(1):7-13. doi: 10.1002/jso.2930550104. J Surg Oncol. 1994. PMID: 8289458

4

Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.

Small EJ, Venook AP, Damon LE. Small EJ, et al. Cancer. 1993 Aug 1;72(3):905-8. doi: 10.1002/1097-0142(19930801)72:3<905::aid-cncr2820720340>3.0.co;2-2. Cancer. 1993. PMID: 8334644 Review.

5

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.

Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. Wilkinson MJ, et al. Among authors: small ej. Cancer. 1993 Jun 1;71(11):3601-4. doi: 10.1002/1097-0142(19930601)71:11<3601::aid-cncr2820711122>3.0.co;2-#. Cancer. 1993. PMID: 8490909 Clinical Trial.

6

The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.

Small EJ, Srinivas S. Small EJ, et al. Cancer. 1995 Oct 15;76(8):1428-34. doi: 10.1002/1097-0142(19951015)76:8<1428::aid-cncr2820760820>3.0.co;2-t. Cancer. 1995. PMID: 8620419

7

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.

Small EJ, Fippin LJ, Ernest ML, Carroll PR. Small EJ, et al. Cancer. 1996 Oct 15;78(8):1775-80. doi: 10.1002/(sici)1097-0142(19961015)78:8<1775::aid-cncr18>3.0.co;2-v. Cancer. 1996. PMID: 8859191 Clinical Trial.

8

Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma.

Small EJ, Baron A, Bok R. Small EJ, et al. Cancer. 1997 Nov 1;80(9):1755-9. doi: 10.1002/(sici)1097-0142(19971101)80:9<1755::aid-cncr9>3.0.co;2-d. Cancer. 1997. PMID: 9351544 Clinical Trial.

9

The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon.

Small EJ, Weiss GR, Malik UK, Walther PJ, Johnson D, Wilding G, Kuzel T, Bajamonde A, Paton V. Small EJ, et al. Cancer J Sci Am. 1998 May-Jun;4(3):162-7. Cancer J Sci Am. 1998. PMID: 9612597 Clinical Trial.

10

Pyrazoloacridine for the treatment of hormone-refractory prostate cancer.

Small EJ, Fippin LJ, Whisenant SP. Small EJ, et al. Cancer Invest. 1998;16(7):456-61. doi: 10.3109/07357909809011699. Cancer Invest. 1998. PMID: 9774952 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters